Intestinal transplantation (IT) is the only effective therapy for irreversible intestinal failure.
小肠移植是治疗不可逆肠衰竭的有效方法。
Conclusion Combined liver and intestinal transplantation is a feasible and effective optimal clinical choice for patients with irreversible intestinal failure and TPN-related liver damage.
结论肝小肠联合移植对肠衰竭合并全肠外营养所致肝功能损害病人，是可行、有效的治疗方法。
Objective to investigate the effect of somatostatin (SST) on the activity of intestinal mucosal mast cells (IMMC) and its pathological significance in the development of multiple organ failure (MOF).
目的探讨生长抑素(SST)对多器官功能衰竭(MOF)时肠黏膜肥大细胞(IMMC)活性的调节及其病理生理意义。
Objective: To investigate changes in activities of the intestinal mucosal mast cells (IMMC) in multiple organ failure (MOF).
目的：研究多器官衰竭(MOF)时肠黏膜肥大细胞(IMMC)活性的变化，从黏膜免疫的角度探讨MOF的病理生理机制。
Objecctive: To explore the pathogenesis of lung injury during multiple system organ failure (MSOF) after traumatic shock by using intestinal ischemia reperfusion model of the rat.
目的：采用大鼠肠缺血再灌注模型，对创伤休克后多系统器官衰竭中肺损伤的发生机制进行研讨。
Objective To observe the histopathologic injury of small intestine and intestinal permeability in chronic renal failure(CRF) rats.
目的探讨慢性肾衰竭（CRF）大鼠肠道通透性及损伤的变化。
Changes in intestinal flora may have a pivotal role in both the elevation of plasma endotoxin and further hepatic lesions resulting in liver failure.
慢性重型肝炎患者肠道菌群的这种变化在其血内毒素水平的升高及肝脏损伤的进一步加重过程中起一定的作用。
Changes in intestinal flora may have a pivotal role in both the elevation of plasma endotoxin and further hepatic lesions resulting in liver failure.
慢性重型肝炎患者肠道菌群的这种变化在其血内毒素水平的升高及肝脏损伤的进一步加重过程中起一定的作用。
应用推荐